Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Another fun factoid: around this time in 2013, the split-adjusted value per share was above $30 Million per share at times…
Maybe…
Hmmmm….
NOTHING helps share price, because they won’t stop diluting.
Yo, Zerify… Quit giving away shares for nothing, unless you think that’s what you’re worth.
Whatever they hope to accomplish by this, could have been achieved in better ways, and it is going to blow up in their faces.
They should know better by now. If FSLR is “eating their lunch”, I reckon they deserve it for doing this to investors who tried to support them.
Stated they might NOT do an RS in the Pre-14C??
This needs to be heading toward .20, not .02.
Tell ‘em to quit diluting.
Need to raise the Ask here…
I have also been noticing Dry Eye symptoms!
had thought it was allergies before…
Need to raise the Ask.
Can we raise the Ask here? Pitiful…
Rather you didn’t use that word, and I don’t agree. Never helps anything.
Send that to the three execs, please.
How do you know “this discounted price won’t last long”? The company keeps diluting millions daily.
Skepticism is appropriate in sub-penny stocks. I just hope they succeed against the odds.
Better communication might help them…
I think you were responding to another person, I didn’t say .04…
Not seeing evidence that anyone is enticed since the move to .02+
So then is Versea licensing the AXIM test strips?
Four weeks is a short time in the big scheme of things…
Can’t maintain .02 share price. So where does the phrase “key players” have any relevance? They aren’t key players in anything while dumping madly 2-3 million shares a day for their own pockets.
Too much hype here, too much dilution, too little share price performance.
But public thinking is slowly changing demand toward more targeted treatments such as immunotherapy…
I hope the company succeeds for the sake of those who need less destructive cancer treatments than those that have prevailed thus far.
Well, you’re asking a kind of “rocket science” question from someone who is not in that field of science, and even so, there is probably some degree of protected “market intelligence” surrounding the answer. I think it is a cut-throat, competitive field, with those invested in maintaining the status quo soundly “in the money”. That the prior company might have failed on financial grounds despite having a workable idea, does not condemn them to my way of thinking. There is massive resistance to innovation in that field.
Why would it stop falling there??
Aug 15 is often an annual low for the markets in general. Then things pick up until Oct 31, then pull back, then often an early Jan rally. Then another low March 7-early April. Then rally into May…. Then drift until mid August again.
I can’t understand why some are selling this below .10. It has that potential, certainly. Very low daily volume.
Chart looks like it’s about time for something to happen.
Not unless Shaun stops diluting the stock to oblivion.
Thanks.
Fabulous…. Thanks!
What previous company was that, if you don’t mind explaining it, and when did they “go bust”??
What’s the MMP-9 test?
It will matter to me. I’m recently invested in this one. Their concept is sound in the cancer research; I’m
not well informed as to their process and how close they are to clinical goals.
Thanks. Though it’s quite appalling, I could add a few tickers to that list…. GTEH, ZRFY, possibly EPAZ… to name a few
On what basis do you publish this opinion?
Whatever the best strategy may be, it would be nice to see the stock back above .05 on some good volume.
I think not - merger with BACK (IMAC).